Skip to main content
. 2024 Feb 27;12:1323102. doi: 10.3389/fpubh.2024.1323102

Table 2.

Differences in clinical outcomes between study groups at baseline (N = 299).

Outcome measures Control group
Mean ± SD
Intervention group Value of p*
FBS (mmol/L) 14.63 ± 1.37 14.51 ± 1.47 0.451
RBS (mmol/L) 17.60 ± 1.14 17.86 ± 1.12 0.056
HbA1c (%) 11.30 ± 1.18 11.41 ± 1.10 0.427
BP systolic (mmHg) 137.54 ± 4.47 139.26 ± 5.39 0.008
BP diastolic (mmHg) 86.66 ± 5.50 87.21 ± 5.77 0.403
T. Cholesterol (mmol/L) 6.03 ± 0.34 6.16 ± 0.35 0.002
Triglyceride (mmol/L) 2.01 ± 0.18 2.06 ± 0.21 0.026
LDL-C (mmol/L) 2.81 ± 0.17 3.87 ± 0.29 0.001
HDL-C (mmol/L) 1.04 ± 0.26 1.00 ± 0.26 0.002

*Two-way ANOVA test.